On May 23, 2019, Thomson Rogers and Rochon Genova LLP issued a class action on behalf of Canadians who were implanted with breast implants manufactured and distributed by Allergan plc and several of its affiliates.
The proposed Canada-wide class action, filed with the Ontario Superior Court of Justice, alleges, among other things, that the defendants knew or ought to have known that the Allergan Implants were associated with breast implant-related illnesses, including several autoimmune, musculoskeletal and neurological disorders, numerous cognitive adverse health effects, as well as the development of breast-implant associated anaplastic large cell lymphoma ("BIA-ALCL"). In spite of having this knowledge, the defendants have failed to warn Canadian patients adequately or at all about these risks and have still not recalled the Allergan Implants in Canada.
The proposed Representative Plaintiff for Canadians with the Allergan Implants is a Toronto woman who has suffered from a variety of serious and debilitating adverse medical effects since having her implant surgery in January of 2014 and who says that if she had been told about the negative side effects of having the implants, or of the risk of developing cancer from the implants, she never would have had the surgery. She is anxious to have her implants surgically removed soon in order to alleviate her symptoms and to hopefully mitigate her risk of developing BIA-ALCL.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.